Psychologist Kimberley Cairns proposes a cognitively informed GLP-1 approach for aesthetic practice Glucagon-like peptide-1 (GLP-1) receptor agonists have reshaped discussions around weight, identity and appearance. In UK aesthetic practice, clinicians are increasingly seeing patients whose bodies, and sometimes decision-making, are …
Subscriber content
Continue reading this clinical article
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
